Dear Reader,
We are delighted to introduce you to the inaugural issue of Journal of Law and the Biosciences ( JLB). JLB is the first peer-reviewed legal journal focused on advances at the intersection of law and the biosciences. A co-venture between Duke University, Harvard Law School, Stanford University, and Oxford University Press, the open-access, online, and interdisciplinary academic journal will publish cutting-edge scholarship in this important new field.
JLB aims to become the source for top interdisciplinary scholarship at the intersection of law and the biosciences. We seek to develop a conversation among lawyers, bioscientists, philosophers, historians, and experts in other disciplines regarding cutting-edge developments in the biosciences, their implications for the law, and the law's implications for them, as well as persistent, unresolved problems or issues at the intersection of law and the biosciences. One of our greatest strengths is our Editorial Board, which comprises of 32 leading experts in a diverse range of fields from top schools across the US, UK, and Canada.
JLB will be published as one volume with three issues per year. New articles will be posted online on an ongoing basis. The journal will publish cutting-edge scholarship on a wide range of topics, including, but not limited to, those pertaining to bioethics, neuroethics, reproductive technologies, stem cells, enhancement, genetics, patent law, and food and drug regulation.
JLB encourages the submission of original manuscripts, responses, and essays devoted to the examination of issues related to the intersection of law and the biosciences. We welcome submissions of varying length, with a theoretical, empirical, practical, or policy oriented focus, including:
Original articles that explore their topic in depth in a manuscript ordinarily not to exceed 20,000 words (all word limits include footnotes) in length, although we will consider articles up to 30,000 words.
Responses to articles, including policy-oriented, research-based, and analytical responses, ordinarily no longer than 10,000 words in length.
Original critical and academic essays up to 10,000 words on topics of contemporary or historical interest.
New developments, which are brief summaries of and commentary on recent legislation, regulation, and case law relevant to the biosciences that are written by students at each of the sponsoring schools and are no longer than 3,000 words.
We hope you enjoy reading this first issue, and we encourage your submissions for future issues.
I. Glenn Cohen, JD
Co-Editor-in-Chief, Journal of Law and the Biosciences, Harvard Law School
Nita Farahany, JD, PhD
Co-Editor-in-Chief, Journal of Law and the Biosciences, Duke University
Hank Greely, JD
Co-Editor-in-Chief, Journal of Law and the Biosciences, Stanford University